Home / Clinical trials / Hexarelin
Are there clinical trials for Hexarelin?
There are no clinical trials registered on ClinicalTrials.gov with Hexarelin as an intervention. No registered trial means no trial results have been submitted to the US registry, so claims about Hexarelin in humans are not supported by registered clinical evidence.
A search of ClinicalTrials.gov for Hexarelin as a registered intervention returns no studies. This is the US registry where clinical trials are required to be listed, so an absence here is meaningful: it means no trial of Hexarelin has been registered, not merely that results are pending.
Frequently asked questions
Are there clinical trials for Hexarelin?
There are no clinical trials registered on ClinicalTrials.gov with Hexarelin as an intervention. No registered trial means no trial results have been submitted to the US registry, so claims about Hexarelin in humans are not supported by registered clinical evidence.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where Hexarelin is registered as an intervention. Last updated 2026-09-23.